https://peptide.exchange/move/glp-1-alcohol-survey-drinkers-cut-backPeptide Exchangeen2026-11-04T04:49:00.000ZGLP 1 alcohol survey finds about half of drinkers cut back on treatment https://peptide.exchange/move/semaglutide-employment-study-wegovy-work-hoursPeptide Exchangeen2026-11-03T05:02:00.000ZSemaglutide employment study ties Wegovy to longer work hours in Denmark https://peptide.exchange/move/malaysia-seizes-unapproved-retatrutidePeptide Exchangeen2026-11-03T04:40:00.000ZMalaysia seizes 697 units of unapproved retatrutide as Lilly readies its FDA filing https://peptide.exchange/move/bivamelagon-license-deal-setmelanotide-royaltyPeptide Exchangeen2026-11-03T03:51:00.000ZBivamelagon license deal cuts setmelanotide royalty to 1 percent